15-Jul-2026
Business Wire (Mon, 15-Jun 7:00 AM ET)
Business Wire (Mon, 8-Jun 7:30 AM ET)
Business Wire (Fri, 29-May 7:00 AM ET)
Business Wire (Fri, 15-May 5:00 PM ET)
Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
Globe Newswire (Thu, 14-May 8:45 AM ET)
Business Wire (Thu, 7-May 7:30 AM ET)
Multibillion-Dollar Edibles Market Gains Rising Momentum as Legalization Expands
Globe Newswire (Thu, 30-Apr 8:30 AM ET)
'There's a Tweed for That': Canopy Growth Announces Tweed Brand Summer Campaign
Business Wire (Thu, 23-Apr 7:30 AM ET)
Canopy Growth's Acquisition of MTL Cannabis Set to Establish New Medical Cannabis Leader in Canada
Market Chameleon (Tue, 16-Dec 5:30 AM ET)
Canopy Growth Bets on Medical Market With Dedicated DOJA Facility—What This Move Signals for CGC
Market Chameleon (Thu, 9-Oct 7:20 AM ET)
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth - Common Shares trades on the NASDAQ stock market under the symbol CGC.
As of July 15, 2026, CGC stock price declined to $0.95 with 1,626,930 million shares trading.
CGC has a beta of 1.39, meaning it tends to be more sensitive to market movements. CGC has a correlation of 0.05 to the broad based SPY ETF.
CGC has a market cap of $402.31 million. This is considered a Small Cap stock.
Last quarter Canopy Growth - Common Shares reported $52 million in Revenue and -$.29 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.23.
In the last 3 years, CGC traded as high as $19.20 and as low as $.77.
The top ETF exchange traded funds that CGC belongs to (by Net Assets): MJ, YOLO.
CGC has underperformed the market in the last year with a price return of -18.5% while the SPY ETF gained +22.0%. CGC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -12.6% and +0.3%, respectively, while the SPY returned +9.0% and +1.1%, respectively.
CGC support price is $.93 and resistance is $.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CGC shares will trade within this expected range on the day.
